The SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) will host the 37th Annual Meeting & Pre-Conference Programs November 8-12, 2022. LamKap Bio beta is very pleased to present for the first time preclinical data on the development of NILK-2401 (CEAxCD47) ± NILK-2301 (CEAxCD28) bispecific antibodies for immunotherapy of patients with carcinoembryonic antigen-related cell adhesion molecule 5 (CEACAM5 aka CEA) expressing solid tumors.
“Novel CEAxCD47 (NILK-2401) and CEAxCD3 (NILK-2301) kl bispecific antibodies for multimodal immunotherapy of CEA-expressing solid cancer” will be presented on site in the Poster Hall on November 10 (abstract no. 853).
Boston Convention and Exhibition Center
415 Summer Street, Boston, MA 02210, USA
